2025 annual financial data
Aligos Therapeutics 2025 Net margin
Aligos Therapeutics 2025 net margin with verified reported values.
Direct answer
Net margin was -1,106.72%.
Operating income was -87,985,000 USD and net income was -24,193,000 USD.
Operating cash flow was -82,503,000 USD.
Get free Aligos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,186,000 USD
- Operating income
- -87,985,000 USD
- Net income
- -24,193,000 USD
- Operating cash flow
- -82,503,000 USD